The menopausal transition may represent an inflection point for worsening of multiple sclerosis in women, according to study findings.

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

One year after being acquired by Global Alzheimer’s Platform Innovations, Tampa-based Axiom Brain Health has expanded its ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

Each year, a striking difference occurs in Australia when Shepard avocados briefly replace Hass at the shops. Here’s why.

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.